Ebola virus disease

ST Jacob, I Crozier, WA Fischer, A Hewlett… - Nature reviews Disease …, 2020 - nature.com
Ebola virus disease (EVD) is a severe and frequently lethal disease caused by Ebola virus
(EBOV). EVD outbreaks typically start from a single case of probable zoonotic transmission …

Beyond binding: antibody effector functions in infectious diseases

LL Lu, TJ Suscovich, SM Fortune, G Alter - Nature Reviews Immunology, 2018 - nature.com
Antibodies play an essential role in host defence against pathogens by recognizing
microorganisms or infected cells. Although preventing pathogen entry is one potential …

A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2

R Shi, C Shan, X Duan, Z Chen, P Liu, J Song, T Song… - Nature, 2020 - nature.com
An outbreak of coronavirus disease 2019 (COVID-19),–, caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), has spread globally. Countermeasures are needed …

Melatonin potentials against viral infections including COVID-19: Current evidence and new findings

KB Juybari, MH Pourhanifeh, A Hosseinzadeh… - Virus research, 2020 - Elsevier
Viral infections are dangerous diseases for human health worldwide, which lead to
significant morbidity and mortality each year. Because of their importance and the lack of …

The pathogenesis of Ebola virus disease

L Baseler, DS Chertow, KM Johnson… - Annual Review of …, 2017 - annualreviews.org
For almost 50 years, ebolaviruses and related filoviruses have been repeatedly reemerging
across the vast equatorial belt of the African continent to cause epidemics of highly fatal …

The Rise and Rise of Nicotiana benthamiana: A Plant for All Reasons

J Bally, H Jung, C Mortimer, F Naim… - Annual review of …, 2018 - annualreviews.org
A decade ago, the value of Nicotiana benthamiana as a tool for plant molecular biologists
was beginning to be appreciated. Scientists were using it to study plant-microbe and protein …

Clinical management of Ebola virus disease in the United States and Europe

TM Uyeki, AK Mehta, RT Davey Jr… - … England Journal of …, 2016 - Mass Medical Soc
Background Available data on the characteristics of patients with Ebola virus disease (EVD)
and clinical management of EVD in settings outside West Africa, as well as the …

Dissecting polyclonal vaccine-induced humoral immunity against HIV using systems serology

AW Chung, MP Kumar, KB Arnold, WH Yu, MK Schoen… - Cell, 2015 - cell.com
While antibody titers and neutralization are considered the gold standard for the selection of
successful vaccines, these parameters are often inadequate predictors of protective …

Defining antigen-specific plasmablast and memory B cell subsets in human blood after viral infection or vaccination

AH Ellebedy, KJL Jackson, HT Kissick, HI Nakaya… - Nature …, 2016 - nature.com
Antigen-specific B cells bifurcate into antibody-secreting cells (ASCs) and memory B cells
(MBCs) after infection or vaccination. ASCs (plasmablasts) have been extensively studied in …

Human Ebola virus infection results in substantial immune activation

AK McElroy, RS Akondy, CW Davis… - Proceedings of the …, 2015 - National Acad Sciences
Four Ebola patients received care at Emory University Hospital, presenting a unique
opportunity to examine the cellular immune responses during acute Ebola virus infection …